Back
Reneo Pharmaceuticals Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
23
RPHM
Reneo Pharmaceuticals
Last Price:
1.50
Seasonality Move:
-26.13%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPHM is experiencing slight buying pressure.
Reneo Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.41 | Buy |
| 20-day SMA: | 1.47 | Buy |
| 50-day SMA: | 1.47 | Buy |
| 200-day SMA: | 1.85 | Sell |
| 8-day EMA: | 1.42 | Buy |
| 20-day EMA: | 1.44 | Buy |
| 50-day EMA: | 1.48 | Buy |
| 200-day EMA: | 2.31 | Sell |
Reneo Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 55.1 | Buy |
| Chaikin Money Flow: | 264572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.4 - 1.56) | Buy |
| Bollinger Bands (100): | (1.44 - 1.7) | Sell |
Reneo Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Reneo Pharmaceuticals Stock
Is Reneo Pharmaceuticals Stock a Buy?
- Reneo Pharmaceuticals share price is 1.50 while RPHM 8-day simple moving average is 1.41, which is a Buy signal.
- The stock price of RPHM is 1.50 while Reneo Pharmaceuticals 20-day SMA is 1.47, which makes it a Buy.
- Reneo Pharmaceuticals 50-day simple moving average is 1.47 while RPHM share price is 1.50, making it a Buy technically.
- RPHM stock price is 1.50 and Reneo Pharmaceuticals 200-day simple moving average is 1.85, creating a Sell signal.
RPHM Technical Analysis vs Fundamental Analysis
Sell
23
Reneo Pharmaceuticals (RPHM)
is a Sell
Is Reneo Pharmaceuticals a Buy or a Sell?
-
Reneo Pharmaceuticals stock is rated a Sell
The current Reneo Pharmaceuticals [RPHM] share price is $1.50. The Score for RPHM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Reneo Pharmaceuticals Stock Info
Market Cap:
50.14M
Price in USD:
1.50
Share Volume:
727.57K
Reneo Pharmaceuticals 52-Week Range
52-Week High:
9.21
52-Week Low:
0.98
Sell
23
Reneo Pharmaceuticals (RPHM)
is a Sell
Reneo Pharmaceuticals Share Price Forecast
-
What is the Reneo Pharmaceuticals stock price today?
The Reneo Pharmaceuticals stock price is 1.50 USD today. -
Will RPHM stock go up or go down?
Reneo Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Reneo Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reneo Pharmaceuticals is overvalued.
Is Reneo Pharmaceuticals Stock a Buy?
- Reneo Pharmaceuticals share price is 1.50 while RPHM 8-day exponential moving average is 1.42, which is a Buy signal.
- The stock price of RPHM is 1.50 while Reneo Pharmaceuticals 20-day EMA is 1.44, which makes it a Buy.
- Reneo Pharmaceuticals 50-day exponential moving average is 1.48 while RPHM share price is 1.50, making it a Buy technically.
- RPHM stock price is 1.50 and Reneo Pharmaceuticals 200-day simple moving average is 2.31, creating a Sell signal.
Fundamental Analysis of Reneo Pharmaceuticals
Is Reneo Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Reneo Pharmaceuticals
Should I short Reneo Pharmaceuticals stock?
- RPHM Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Reneo Pharmaceuticals is a Sell
- Reneo Pharmaceuticals Relative Strength Index (RSI) is 55.1, which suggest Reneo Pharmaceuticals is overbought
- The Bollinger Bands (25) for Reneo Pharmaceuticals is (1.4 - 1.56), which suggest Reneo Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Reneo Pharmaceuticals is (1.44 - 1.7), which suggest Reneo Pharmaceuticals is a Sell
* Reneo Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.